alphaveBIOFILCHEM₹36.00

Biofil Chemicals & Pharmaceuticals Limited

₹ CrorePeersMANGALAM VINEETLAB LASA ORTINGLOBE KREBSBIO ALPA BALPHARMA NATCAPSUQMcap ₹58.6 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Non-current Assets
+ Property, Plant & Equipment	8.6	8.3	6.9	6.9
+ Other Non-current Assets	0.1	0.1	0.1	0.1
Total Non-current Assets	8.7	8.4	7.0	7.0
Current Assets
+ Inventories	2.5	3.3	4.0	4.0
+ Trade Receivables	33.0	38.3	27.6	27.6
+ Cash & Cash Equivalents	0.1	0.1	0.1	0.1
+ Other Bank Balances	2.2	0.1	3.3	3.3
+ Other Current Financial Assets	—	0.6	—	—
Current Financial Assets	35.3	39.2	30.9	30.9
+ Other Current Assets	0.5	—	1.0	1.0
Total Current Assets	38.4	42.6	35.9	35.9
Total Assets	47.1	51.0	42.8	42.8
Equity
+ Equity Share Capital	16.3	16.3	16.3	16.3
+ Other Equity / Reserves	1.9	2.5	5.3	5.3
Equity — Owners of Parent	18.2	18.8	21.6	21.6
Total Equity	18.2	18.8	21.6	21.6
Liabilities
+ Deferred Tax Liabilities	0.4	0.3	0.6	0.6
Non-current Liabilities	0.4	0.3	0.6	0.6
+ Borrowings — Current	0.4	0.5	3.0	3.0
+ Trade Payables	27.6	31.0	17.1	17.1
Current Financial Liabilities	28.0	31.5	20.1	20.1
+ Provisions — Current	0.2	0.2	0.4	0.4
+ Other Current Liabilities	0.3	0.2	0.2	0.2
Current Liabilities	28.5	31.8	20.7	20.7
Total Liabilities	28.9	32.2	21.3	21.3
Total Equity & Liabilities	47.1	51.0	42.8	42.8
Trade Payables — MSME split
+ Dues to Other Creditors — Current	—	31.0	17.1	17.1

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.